Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $628.29 billion, total revenue of $162.77 billion and a weighted average PE ratio of 46.38.
Market Cap
628.29B
Revenue
162.77B
Profits
13.55B
PE Ratio
46.38
Profit Margin
8.32%
Dividend Yield
0.24%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 174.79B | -0.99% | 2,756,621 | 43.21B |
| 2 | DHR | Danaher Corporation | 141.13B | -0.04% | 5,735,776 | 24.01B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.07B | 0.23% | 760,405 | 3.93B |
| 4 | A | Agilent Technologies, Inc. | 32.24B | -1.14% | 1,888,106 | 6.63B |
| 5 | IQV | IQVIA Holdings Inc. | 31.02B | -1.83% | 1,644,091 | 15.70B |
| 6 | MTD | Mettler-Toledo International Inc. | 24.66B | -2.95% | 339,592 | 3.87B |
| 7 | LH | Labcorp Holdings Inc. | 21.73B | 0.55% | 652,882 | 13.48B |
| 8 | DGX | Quest Diagnostics Incorporated | 19.11B | 2.05% | 1,421,069 | 10.52B |
| 9 | NTRA | Natera, Inc. | 18.38B | 0.69% | 1,165,771 | 1.83B |
| 10 | WAT | Waters Corporation | 17.28B | 0.54% | 1,201,348 | 2.98B |
| 11 | ILMN | Illumina, Inc. | 14.55B | -7.84% | 4,770,929 | 4.28B |
| 12 | ICLR | ICON Public Limited Company | 12.94B | -1.63% | 1,130,302 | 8.09B |
| 13 | MEDP | Medpace Holdings, Inc. | 11.89B | -0.96% | 517,836 | 2.23B |
| 14 | QGEN | Qiagen N.V. | 10.81B | 1.22% | 1,448,114 | 2.00B |
| 15 | RVTY | Revvity, Inc. | 10.40B | 0.38% | 1,601,056 | 2.80B |
| 16 | EXAS | Exact Sciences Corporation | 9.01B | 1.73% | 2,535,851 | 2.83B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.20B | -1.61% | 823,620 | 4.02B |
| 18 | GH | Guardant Health, Inc. | 5.17B | 1.07% | 3,157,876 | 828.85M |
| 19 | RDNT | RadNet, Inc. | 4.20B | -0.02% | 574,697 | 1.87B |
| 20 | SHC | Sotera Health Company | 3.16B | -2.96% | 935,180 | 1.11B |
| 21 | WGS | GeneDx Holdings Corp. | 2.92B | -0.34% | 834,973 | 362.32M |
| 22 | TWST | Twist Bioscience Corporation | 2.02B | 0.33% | 1,376,454 | 347.68M |
| 23 | VCYT | Veracyte, Inc. | 1.85B | 0.55% | 1,741,575 | 463.39M |
| 24 | GRAL | GRAIL, Inc. | 1.18B | -4.15% | 850,540 | 130.71M |
| 25 | NEOG | Neogen Corporation | 1.01B | 0.22% | 6,055,445 | 894.66M |
| 26 | OPK | OPKO Health, Inc. | 944.60M | -7.03% | 7,424,470 | 664.03M |
| 27 | CDNA | CareDx, Inc | 680.42M | -0.57% | 969,666 | 346.42M |
| 28 | NEO | NeoGenomics, Inc. | 666.56M | 6.61% | 4,529,135 | 689.19M |
| 29 | FLGT | Fulgent Genetics, Inc. | 567.19M | 7.80% | 1,079,729 | 303.22M |
| 30 | PSNL | Personalis, Inc. | 476.07M | -1.64% | 854,003 | 85.69M |
| 31 | CSTL | Castle Biosciences, Inc. | 422.98M | -3.30% | 419,523 | 347.08M |
| 32 | MYGN | Myriad Genetics, Inc. | 360.41M | 1.69% | 1,404,610 | 831.30M |
| 33 | XGN | Exagen Inc. | 189.89M | 2.74% | 282,734 | 58.86M |
| 34 | MDXH | MDxHealth SA | 120.28M | 0.84% | 192,289 | 94.51M |
| 35 | PRE | Prenetics Global Limited | 104.27M | -0.87% | 72,770 | 41.52M |
| 36 | FONR | FONAR Corporation | 98.47M | 0.13% | 14,549 | 103.02M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 73.21M | 1.59% | 15,183 | 3.84M |
| 38 | NOTV | Inotiv, Inc. | 65.96M | -4.48% | 312,217 | 480.40M |
| 39 | BNR | Burning Rock Biotech Limited | 61.05M | -1.56% | 23,461 | 72.11M |
| 40 | BDSX | Biodesix, Inc. | 53.23M | 3.27% | 471,241 | 74.46M |
| 41 | PRPO | Precipio, Inc. | 21.93M | 1.40% | 1,958 | 20.03M |
| 42 | PRPH | ProPhase Labs, Inc. | 13.55M | -9.34% | 785,761 | 5.85M |
| 43 | ADVB | Advanced Biomed Inc. | 9.25M | -7.57% | 297,353 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 8.08M | -7.38% | 604,807 | 8.81M |
| 45 | STRR | Star Equity Holdings, Inc. | 6.48M | -0.49% | 26,397 | 57.17M |
| 46 | ISPC | iSpecimen Inc. | 5.85M | 18.55% | 714,676 | 8.06M |
| 47 | XWEL | XWELL, Inc. | 5.31M | -0.49% | 9,793 | 32.19M |
| 48 | MYNZ | Mainz Biomed N.V. | 4.58M | -22.22% | 502,861 | 893.99K |
| 49 | CHEK | Check-Cap Ltd. | 3.96M | -8.47% | 49,100 | - |
| 50 | NDRA | ENDRA Life Sciences Inc. | 3.57M | -8.33% | 27,257 | - |
| 51 | APDN | Applied DNA Sciences, Inc. | 2.38M | -1.30% | 33,141 | 3.79M |